Revenue: The sum of all revenue fields included for a company's operating activities.
Century Therapeutics, Inc. (IPSC) had Revenue of $6.59M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$6.59M |
$-126.57M |
|
-- |
|
$6.59M |
|
$144.73M |
|
$-138.14M |
|
$13.36M |
|
$-124.78M |
|
$-124.78M |
|
$-126.57M |
|
$-126.57M |
|
$-126.57M |
|
$-126.57M |
|
$-138.14M |
|
$-129.65M |
|
78.65M |
|
78.65M |
|
$-1.61 |
|
$-1.61 |
|
| Balance Sheet Financials | |
$194.05M |
|
$62.14M |
|
$159.16M |
|
$353.22M |
|
$129.78M |
|
-- |
|
$62.07M |
|
$191.85M |
|
$161.36M |
|
$127.16M |
|
$161.36M |
|
85.84M |
|
| Cash Flow Statement Financials | |
$-110.14M |
|
$47.48M |
|
$74.56M |
|
$49.30M |
|
$61.21M |
|
$11.91M |
|
$12.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.50 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
100.00% |
|
-2096.48% |
|
-2096.48% |
|
-1967.60% |
|
-1893.70% |
|
-1920.87% |
|
$-110.29M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-78.44% |
|
-99.53% |
|
-35.83% |
|
-78.44% |
|
$1.88 |
|
$-1.40 |
|
$-1.40 |
|